Question Completion with Options:
2.5 percentage points
1.5 percentage points
3.5 percentage points
6.5 percentage points
Answer:
Sandra's creditor must determine if the APR for the loan exceeds the average prime offer rate by:
1.5 percentage points
Explanation:
The first mortgage loan principal should not exceed the conforming loan limit for the area where Sandra lives at the time that she secures the loan approval. It behooves on Sandra’s creditor to determine if the annual percentage rate (APR) for the mortgage loan exceeds the average prime offer rate (or the sample rate that is a representative of the APRs charged by creditors for mortgage loans that have low-risk pricing characteristics) by 1.5 percentage points.
Answer: ER(P) = Rf + β(Rm-Rf)
6 = 5 + β(17-5)
6 = 5 + β(12 )
6 - 5 = 12β
1 = 12β
β = 1/12
β = 0.083
Explanation: In determining the Beta of the stock, we need to apply capital asset pricing formula and then make Beta the subject of the formula. Other variables will be substituted with the exception of Beta, which becomes the subject of the formula.
Answer:
- I think Ben should encourage the Senior Management to call a multidisciplynary meeting and do some research.
Explanation:
<em>I think Ben is right</em>. Even though the statement is technically correct, it may mislead customers.
Customers may interpret the phrase "<em>no sugar added</em>" as if the product did not contain any sugar.
Thus, customers interested in drinking beverages without sugar at all might think they are "safe" consuming the smoothie beverage, when in reallity each <em>smoothie's bottle contains sugar 35 g of naturally occurring sugars from the fruit.</em>
Customers deserve to be certain on what they are buying, thus the labels must be a sincere help for them, and not ambiguos at all.
This is a "gray zone" and an example of what in ethics is called a dilema.
I think the decision should be shared by a wider team and based on some research.
I think Ben should encourage the Senior Management to call a multidisciplynary meeting, where the subject is widely discussed. Also, I would suggest Ben to do some research, look for precedents about labeling in the industry, and try to learn the opinion of the FDA about this sensitive matter.